Pharmacological suppression of TREM-1 or epigenetic TREM-1 modification reduces atherosclerosis and the incidence of AMI in a mouse model with a notably low death rate, and it can also help individuals who are at risk of endocarditis inflammation [8,54,55,56,57]. The gene discussed is TREM1; the disease is atherosclerosis.